Aesthetic Surgery Journal
An Analysis of Safety Data from Five Phase III Clinical Trials on the Use of Botulinum Neurotoxin Type A-ABO for the Treatment of Glabellar Lines
Mark Rubin, MD; Jeffrey Dover, MD, FRCPC; Corey Maas, MD; and Mark Nestor, MD, PhD